Infectious disease patent intelligence

US 6787573

Antiviral therapy

Universitair Medisch Centrum Utrecht · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6780414

METHODS OF IDENTIFYING BACTERIAL GENES THAT ARE INCOMPATIBLE WITH BACTERIAL PATHOGENICITY, AND THE USE OF SUCH GENES, SUCH AS CADA, TO REDUCE PATHOGENICITY IN A BACTERIA OR TO COMBAT PATHOGENIC BACTERIAL INFECTIONS

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6780417

Transmission blocking immunogen from malaria

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6780890

Compounds and methods for regulating bacterial growth and pathogenesis

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6780969

Synthetic peptide composition as immunogens for prevention of urinary tract infection

United Biomedical, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6777179

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6759538

Substituted diphenyl heterocycles useful for treating HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6750043

Viral vectors having reduced virulence

THE ARIZONA BOARD OF REGENTS · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6743577

Methods of using cyanovirins to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6737051

Cell compositions containing macrophages, presenting anti-infectious and hematopoietic properties

I.D.M. Immuno-Designed Molecules · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6720415

Compositions and methods for regulating bacterial pathogenesis

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6720308

Anhydrolide derivatives having antibacterial activity

Enanta Pharmaceuticals, Inc. · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713078

Retrocyclins: antiviral and antimicrobial peptides

The Regents of the University of California · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713056

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

I.D.M. Immuno-Designed Molecules · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6709649

RANTES derived peptides with anti-HIV activity

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6705556

Composition and method for inducing tolerance to viral infection in aquatic animals

First Republic Corporation of America · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6703232

Method of producing infectious reovirus

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6689877

Methods and compositions for the treatment of human immunodeficiency virus infection

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6689362

Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6689767

Triterpenes having antibacterial activity

Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6685949

Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6686333

Inhibition of HIV replication using soluble Tat peptide analogs

The United States of America as represented by the Department of Health and Human Resources · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6686190

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6682728

Efficient and selective adenoviral-mediated gene transfer into vascular neointima

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6673591

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6673346

Compositions and methods for the treatment of sepsis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6667152

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6663857

In vivo gene transfer using implanted retroviral producer cells

The Regents of the University of California · Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6663858

In Vivo gene transfer using implanted retroviral producer cells

The Regents of the University of California · Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6660750

Flavopiridol methods and compositions for HIV therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6656471

HIV-specific T-cell induction

The Board of Regents of the University of Texas System · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6656706

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6644320

Treatment of hepatitis C using hyperthermia

First Circle Medical, Inc. · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6638919

Antiviral purine derivatives

University College Cardiff Consultants Limited · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6630344

Diminishing viral gene expression by promoter replacement

Texas Systems, University of the Board of the Regents · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6627641

Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6623961

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6624140

Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome

Academisch Ziekenhuis Bij de Universiteit van Amsterdam Academisch Medisch Centrum · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6617441

Diagnostic test for borrelia infection

The Board of Regents of the University of Texas · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6617309

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6616925

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

I.D.M. Immuno-Designed Molecules · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6610476

Detection of HIV-1 DNA

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6599739

Infectious papillomavirus pseudoviral particles

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6599744

Viral expression vectors comprising a ribosomal promoter sequence

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)